Intermittent androgen therapy
Abi Aad, A.S.; Van Cangh, P.J.
Acta Urologica Belgica 64(2): 91-92
1996
ISSN/ISBN: 0001-7183 PMID: 8701823 Document Number: 459193
Document emailed within 1 workday
Related Documents
Koivisto, P.; Kononen, J.; Palmberg, C.; Tammela, T.; Hyytinen, E.; Isola, J.; Trapman, J.; Cleutjens, K.; Noordzij, A.; Visakorpi, T.; Kallioniemi, O.P. 1997: Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer Cancer Research 57(2): 314-319Leschke, M.; Mecklenbeck, W.; Strauer, B.E. 1992: Chronic intermittent urokinase therapy in inoperable end-stage coronary disease with therapy refractory angina pectoris symptoms Medizinische Klinik 87(7): 385-389
Pettaway, C.A. 1999: Racial differences in the androgen/androgen receptor pathway in prostate cancer Journal of the National Medical Association 91(12): 653-660
Yen, J-Lung.; Chang, K-Huey.; Sheu, J-Cherng.; Lee, Y-Jinn.; Tsai, L-Ping. 2005: Partial androgen insensitivity syndrome with R840H mutation in androgen receptor: report of one case Acta Paediatrica Taiwanica 46(2): 101-105
Nickel, B.; Schwartz, A.; Rosenmann, E.; Kaufman, M.; Pinsky, L.; Wrogemann, K. 1988: A study of androgen-resistant subjects indicates that the 6.7 pI/56 kDa protein in genital skin fibroblasts is related to the androgen receptor Clinical and Investigative Medicine. Medecine Clinique et Experimentale 11(1): 22-33
Izbicka, E.; MacDonald, J.R.; Davidson, K.; Lawrence, R.A.; Gomez, L.; Von Hoff, D.D. 1999: 5,6 Dihydro-5'-azacytidine (DHAC) restores androgen responsiveness in androgen-insensitive prostate cancer cells Anticancer Research 19(2a): 1285-1291
Bastos, D.A.; Dzik, C.; Rathkopf, D.; Scher, H.I. 2014: Expanding androgen- and androgen receptor signaling-directed therapies for castration-resistant prostate cancer Oncology 28(8): 693-699
Sultan, C. 1986: Androgen receptors and partial androgen insensitivity in male pseudohermaphroditism Annales de Genetique 29(1): 5-10
Morton, A.P. 2004: Androgen deficiency and replacement therapy in men Medical Journal of Australia 181(5): 286; Author Reply 286-7
Shimazui, T. 2011: Maximally androgen blockade therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 5): 477-480
Barats, S.S.; Iordanidi, S.A. 1973: Androgen excretion in men in angina pectoris and cardialgia and changes in lipoprotein metabolism and in the blood coagulation system in androgen deficiency Kardiologiia 13(8): 74-77
Amler, L.C.; Agus, D.B.; LeDuc, C.; Sapinoso, M.L.; Fox, W.D.; Kern, S.; Lee, D.; Wang, V.; Leysens, M.; Higgins, B.; Martin, J.; Gerald, W.; Dracopoli, N.; Cordon-Cardo, C.; Scher, H.I.; Hampton, G.M. 2000: Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1 Cancer Research 60(21): 6134-6141
Gu, Y.; Kim, K-Hong.; Ko, D.; Srivastava, S.; Moul, J.W.; McLeod, D.G.; Rhim, J.S. 2005: Androgen and androgen receptor antagonist responsive primary African-American benign prostate epithelial cell line Anticancer Research 25(1a): 1-8
Lumbroso, S.; Lobaccaro, J.M.; Belon, C.; Amram, S.; Rodier, M.; Bringer, J.; Sultan, C. 1993: Familial form of partial androgen insensitivity (Reifenstein syndrome): arginine-histidine mutation in position 840 in the androgen receptor Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 187(4): 508-515
Lobaccaro, J.M.; Lumbroso, S.; Sultan, C. 1991: Androgen receptor gene polymorphism analysis: application to screening of heterozygote and to prenatal diagnosis of androgen insensitivity syndrome Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 185(6): 422-433
Chinoy, M.R.; Chinoy, N.J. 1983: Differential androgen requirements of proximal and distal vas deferens of albino rats and possible potentiation of androgen action by ascorbic acid Indian Journal of Experimental Biology 21(6): 335-338
Rees, J. 2015: Androgen deprivation therapy and cardiovascular risk Practitioner 259(1785): 5
Beuzeboc, P.; Richaud, P. 2003: Androgen replacement therapy and prostate cancer Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 13(5 Suppl 2: 1276-1277
Sugimoto, K.; Ohzato, H.; Tomita, N.; Tamura, S.; Aihara, T.; Okamura, S.; Miki, H.; Nakata, K.; Kim, C.; Takiuchi, D.; Okada, K.; Takatsuka, Y. 2005: Two cases of successful local control with intermittent hepatic arterial infusion therapy using 5-FU and external radiation therapy for unresectable advanced gall bladder cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(11): 1855-1858
Pichler, W.J.; Lehner, R.; Späth, P.J. 1989: Recurrent angioedema associated with hypogonadism or anti-androgen therapy Annals of Allergy 63(4): 301-305